Freedom-1 Study for Chronic Knee Pain
for Osteoarthritic Knee Pain
Sites in Houston, San Antonio +11 more locations
Sponsor: Curonix LLC
Sex: All·Age: 18+
Code: NCT03877653·Recruiting·Listed Mar 2019
Paid Clinical Trials in Texas
Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
4,652 clinical trials
Get a weekly email when new trials open in Houston, TX.
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
for NHL
Sites in Houston +8 more locations
Sponsor: Indapta Therapeutics, INC.
Sex: All·Age: 18+
Code: NCT06119685·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
for Diabetic Foot Ulcer
Sites in Houston +9 more locations
Sponsor: Energenesis Biomedical Co., Ltd.
Sex: All·Age: 18+
Code: NCT05930210·Phase 3·Recruiting·Listed Jul 2023
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for Schizophrenia
Sites in Austin, Richardson +16 more locations
Sponsor: Reviva Pharmaceuticals
Sex: All·Age: 18 - 65·Accepts healthy volunteers
Code: NCT05184335·Phase 3·Recruiting·Listed Jan 2022
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
for Ischemic Stroke
Sites in Houston +13 more locations
Sponsor: BrainQ Technologies Ltd.
Sex: All·Age: 22 - 80
Code: NCT06386874·Recruiting·Listed Apr 2024
Phase 1b/2 Study of IV Sarilumab in Adult With RA
for Rheumatoid Arthritis
Sites in Plano +3 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07704580·Phase 1, Phase 2·Recruiting·Listed Jul 2026
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
for Advanced or Metastatic Solid Tumors
Sites in Houston, San Antonio +2 more locations
Sponsor: SHY Therapeutics
Sex: All·Age: 18+
Code: NCT07705334·Phase 1·Recruiting·Listed Jul 2026
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
for Recessive Dystrophic Epidermolysis Bullosa
Sites in Galveston +3 more locations
Sponsor: Abeona Therapeutics, Inc
Sex: All·Age: All ages
Code: NCT07700966·Recruiting·Listed Jul 2026
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
for Idiopathic Pulmonary Fibrosis
Sites in Houston, El Paso +13 more locations
Sponsor: Trevi Therapeutics
Sex: All·Age: 40+
Code: NCT07671911·Phase 3·Recruiting·Listed Jun 2026
Study of NTB-928 in R/R OC
for Relapsed/Refractory Ovarian Carcinoma
Sites in Fort Worth +3 more locations
Sponsor: TeneoSeven, Inc.
Sex: Female·Age: 18+
Code: NCT07690189·Phase 1·Recruiting·Listed Jul 2026
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
for Obesity
Sites in San Antonio +1 more location
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 65·Accepts healthy volunteers
Code: NCT07654972·Phase 1·Recruiting·Listed Jun 2026
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
for Papulopustular Rosacea
Drug: Remibrutinib
1 location in El Paso
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07681271·Phase 2·Recruiting·Listed Jul 2026
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
for Locally Advanced (Unresectable) or Metastatic Solid Tumors
Sites in Houston, Dallas +7 more locations
Sponsor: NEOK Bio, Inc.
Sex: All·Age: 18+
Code: NCT07612176·Phase 1·Recruiting·Listed May 2026
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
for Locally Advanced (Unresectable) or Metastatic Solid Tumors
Sites in Houston, Dallas +8 more locations
Sponsor: NEOK Bio, Inc.
Sex: All·Age: 18+
Code: NCT07612189·Phase 1·Recruiting·Listed May 2026
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for Colorectal Cancer
Sites in Houston, Fort Worth +10 more locations
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07659795·Phase 2·Recruiting·Listed Jun 2026
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
for Malignant Neoplasm
Sites in Houston +11 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 1 Month - 17
Code: NCT07630974·Phase 1, Phase 2·Recruiting·Listed Jun 2026
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
for Lipoprotein(a)
Sites in Houston, Tomball +22 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07614984·Phase 2·Recruiting·Listed May 2026
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
for Myasthenia Gravis, Generalized
Sites in Houston +2 more locations
Sponsor: Dianthus Therapeutics
Sex: All·Age: 18 - 80
Code: NCT07647510·Phase 3·Recruiting·Listed Jun 2026
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
for Schizophrenia
Sites in Austin, Richardson +6 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 55
Code: NCT07615426·Phase 1·Recruiting·Listed May 2026
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
for Sjögren´s Disease
Drug: Ianalumab
Sites in Houston, Bellaire +14 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07621809·Phase 3·Recruiting·Listed Jun 2026
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for HIV-1-infection
Sites in Houston, Dallas +38 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT07645287·Phase 2·Recruiting·Listed Jun 2026
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
for Rheumatoid Arthritis
Drug: Afimkibart
Sites in Houston, Tomball +2 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07620392·Phase 2·Recruiting·Listed Jun 2026
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
for Acute Treatment of Migraine
Drug: Rimegepant
Sites in Dallas, Austin +10 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07609914·Phase 4·Recruiting·Listed May 2026
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
for Limbal Stem Cell Deficiency
Sites in San Antonio +7 more locations
Sponsor: Claris Biotherapeutics, Inc.
Sex: All·Age: 12 - 99
Code: NCT07636590·Recruiting·Listed Jun 2026
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies
for Advanced Malignancies
Sites in Houston, Fort Worth +4 more locations
Sponsor: PharmaMar
Sex: All·Age: 18+
Code: NCT07644039·Phase 1, Phase 2·Recruiting·Listed Jun 2026
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
for Focal Seizure
Sites in Houston +10 more locations
Sponsor: Rapport Therapeutics Inc.
Sex: All·Age: 18 - 75
Code: NCT07594119·Phase 3·Recruiting·Listed May 2026
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
for Malignant Neoplasm
1 location in San Antonio
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07600749·Phase 1·Recruiting·Listed May 2026
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
for Optic Neuritis
Sites in Houston, Dallas +2 more locations
Sponsor: Oculis
Sex: All·Age: 18 - 50
Code: NCT07623668·Phase 3·Recruiting·Listed Jun 2026
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
for Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Drug: Ixo-vec
Sites in The Woodlands +11 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07630649·Phase 2·Recruiting·Listed Jun 2026
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
for Major Depressive Disorder (MDD)
Sites in Fort Worth, DeSoto +21 more locations
Sponsor: Draig Therapeutics Ltd
Sex: All·Age: 18 - 75
Code: NCT07610473·Phase 2·Recruiting·Listed May 2026
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
for Lower Extremity Lymphedema
1 location in Houston
Sponsor: Tactile Medical
Sex: All·Age: 18+
Code: NCT07613931·EARLY_Phase 1·Recruiting·Listed May 2026
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
for Lymphoblastic Lymphoma
Sites in Houston, Fort Worth +5 more locations
Sponsor: Allterum Therapeutics, Inc
Sex: All·Age: 18+
Code: NCT07586618·Phase 1·Recruiting·Listed May 2026
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
for Advanced HR+/HER2- Breast Cancer
Sites in Dallas +1 more location
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07604571·Phase 1·Recruiting·Listed May 2026
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
for LMNA-Related Dilated Cardiomyopathy
Sites in Houston +7 more locations
Sponsor: Nuevocor Pte. Ltd.
Sex: All·Age: 18+
Code: NCT07606274·Phase 1, Phase 2·Recruiting·Listed May 2026
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
for Narcolepsy Type 1
Sites in Dallas, San Antonio +18 more locations
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All·Age: 18 - 70
Code: NCT07598708·Phase 2, Phase 3·Recruiting·Listed May 2026
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation
for Inclisiran Formulation
Drug: Inclisiran
Sites in San Antonio +2 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 60·Accepts healthy volunteers
Code: NCT07626281·Phase 1·Recruiting·Listed Jun 2026
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
for Colorectal Cancer
Sites in Irving +2 more locations
Sponsor: Immunome, Inc.
Sex: All·Age: 18+
Code: NCT07578571·Phase 1·Recruiting·Listed May 2026
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
for COPD (Chronic Obstructive Pulmonary Disease)
Sites in McKinney +3 more locations
Sponsor: Windward Bio
Sex: All·Age: 40 - 80
Code: NCT07646587·Phase 2·Recruiting·Listed Jun 2026
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
for Type 1 Diabetes (T1D)
Sites in Austin +5 more locations
Sponsor: DreaMed Diabetes
Sex: All·Age: 18 - 80
Code: NCT07599982·Recruiting·Listed May 2026
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in San Antonio, Austin +17 more locations
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All·Age: 18+
Code: NCT07549412·Phase 3·Recruiting·Listed Apr 2026